Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Determining and understanding the control of glycolysis in fast‐growth tumor cells: Flux control by an over‐expressed but strongly product‐inhibited hexokinase

Open access
Marín‐Hernández, Alvaro, Rodríguez‐Enríquez, Sara, Vital‐González, Paola A., Flores‐Rodríguez, Fanny L., Macías‐Silva, Marina, Sosa‐Garrocho, Marcela, Moreno‐Sánchez, Rafael·2006·The FEBS Journal

Abstract

Control analysis of the glycolytic flux was carried out in two fast‐growth tumor cell types of human and rodent origin (HeLa and AS‐30D, respectively). Determination of the maximal velocity (Vmax) of the 10 glycolytic enzymes from hexokinase to lactate dehydrogenase revealed that hexokinase (153–306 times) and phosphfructokinase‐1 (PFK‐1) (22–56 times) had higher over‐expression in rat AS‐30D hepatoma cells than in normal freshly isolated rat hepatocytes. Moreover, the steady‐state concentrations of the glycolytic metabolites, particularly those of the products of hexokinase and PFK‐1, were increased compared with hepatocytes. In HeLa cells, Vmax values and metabolite concentrations for the 10 glycolytic enzyme were also significantly increased, but to a much lesser extent (6–9 times for both hexokinase and PFK‐1). Elasticity‐based analysis of the glycolytic flux in AS‐30D cells showed that the block of enzymes producing Fru(1,6)P2 (i.e. glucose transporter, hexokinase, hexosephosphate isomerase, PFK‐1, and the Glc6 P branches) exerted most of the flux control (70–75%), whereas the consuming block (from aldolase to lactate dehydrogenase) exhibited the remaining control. The Glc6 P‐producing block (glucose transporter and hexokinase) also showed high flux control (70%), which indicated low flux control by PFK‐1. Kinetic analysis of PFK‐1 showed low sensitivity towards its allosteric inhibitors citrate and ATP, at physiological concentrations of the activator Fru(2,6)P2. On the other hand, hexokinase activity was strongly inhibited by high, but physiological, concentrations of Glc6 P. Therefore, the enhanced glycolytic flux in fast‐growth tumor cells was still controlled by an over‐produced, but Glc6 P‐inhibited hexokinase.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2006.05214.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 65

  1. 10.1126/science.124.3215.269 · DOI · Paper page
  2. 10.1016/j.bbrc.2003.11.136 · DOI · Paper page
  3. 10.1016/S0968-0004(98)01344-9 · DOI · Paper page
  4. 10.1074/jbc.M202487200 · DOI · Paper page
  5. 10.1074/jbc.C000023200 · DOI · Paper page
  6. 10.1073/pnas.87.19.7414 · DOI
  7. Nakashima R, 1988, Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS‐30D rat hepatoma cell line, Cancer Res, 48, 913
  8. 10.1016/S0005-2728(02)00248-7 · DOI · Paper page
  9. 10.1074/jbc.M300608200 · DOI
  10. 10.1074/jbc.272.36.22776 · DOI · Paper page
  11. 10.1074/jbc.M109950200 · DOI · Paper page
  12. 10.1046/j.1432-1327.1998.2580277.x · DOI · Paper page
  13. Staal GEJ, 1987, Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase, from human gliomas, Cancer Res, 47, 5047
  14. 10.1016/S0021-9258(20)81851-1 · DOI
  15. Oskam R, 1985, Isozymic composition and regulatory properties of phosphofructokinase from well‐differentiated and anaplastic medullary thyroid carcinomas of the rat, Cancer Res, 45, 135
  16. Vora S, 1985, Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation‐and progression‐linked discriminants of malignancy, Cancer Res, 45, 2993
  17. 10.1016/S0014-5793(97)00496-1 · DOI
  18. 10.1042/bj2390531 · doi:10.1042/bj2390531
  19. 10.1042/bj2320521 · DOI
  20. Loiseau AM, 1985, Fructose‐2,6‐bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells, Cancer Res, 45, 4263
  21. 10.1007/BF01213320 · DOI
  22. 10.1111/j.1432-1033.1974.tb03320.x · DOI · Paper page
  23. 10.1016/S0021-9258(18)47278-X · DOI · Paper page
  24. Fell D, 1997, Understanding the Control of Metabolism
  25. 10.1016/S0021-9258(18)69674-7 · DOI · Paper page
  26. 10.1042/bj1480545 · DOI
  27. 10.1159/000401202 · DOI · Paper page
  28. 10.1016/0020-711X(91)90212-6 · DOI
  29. 10.1016/S0021-9258(19)81026-8 · DOI · Paper page
  30. 10.1042/bst0110035 · DOI · Paper page
  31. 10.1046/j.1432-1327.1999.00621.x · DOI
  32. 10.1042/bj2370379 · DOI · Paper page
  33. 10.1111/j.1432-1033.1990.tb15405.x · DOI · Paper page
  34. 10.1042/bj3220119 · DOI
  35. 10.1046/j.1432-1327.1999.00534.x · DOI
  36. 10.1016/S0014-5793(99)00117-9 · doi:10.1016/s0014-5793(99)00117-9
  37. Eigenbrodt E, 1985, Regulation of Carbohydrate Metabolism, 141
  38. Rodríguez‐Enríquez S, 1998, Intermediary metabolism of fast‐growth tumor cells, Arch Med Res, 29, 1
  39. 10.1002/(SICI)1097-4652(199910)181:1<136::AID-JCP14>3.0.CO;2-T · DOI
  40. 10.1074/jbc.272.8.4941 · DOI
  41. 10.1016/0301-4622(93)80037-J · DOI
  42. 10.1016/S0005-2728(98)00130-3 · DOI
  43. 10.1111/j.1432-1033.1990.tb19234.x · DOI · Paper page
  44. 10.1242/jcs.108.12.3735 · DOI
  45. 10.1002/jcp.20166 · DOI · Paper page
  46. 10.1042/bj2900701 · DOI · Paper page
  47. 10.1046/j.1432-1327.2001.02140.x · DOI
  48. 10.1111/j.1432-1033.1975.tb04107.x · DOI
  49. 10.1016/S0005-2760(97)00120-3 · DOI
  50. 10.1016/j.jtbi.2005.07.003 · DOI
  51. 10.1073/pnas.74.9.3735 · DOI · Paper page
  52. Smith TAD, 2000, Mammalian hexokinases and their abnormal expression in cancer, Br J Biomed Sci, 57, 170
  53. 10.1016/S0021-9258(19)77853-3 · DOI · Paper page
  54. 10.1016/S0021-9258(17)44361-4 · DOI
  55. Atsumi T, 2002, High expression of inducible 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase (iPFK‐2; PFKFB3) in human cancers, Cancer Res, 62, 5881
  56. 10.1073/pnas.96.6.3047 · DOI · Paper page
  57. 10.1016/0020-711X(93)90627-Q · DOI
  58. 10.1083/jcb.43.3.506 · DOI · Paper page
  59. 10.1016/B978-0-12-091302-2.50109-2 · DOI · Paper page
  60. 10.1016/S0021-9258(18)57021-6 · DOI · Paper page
  61. Bergmeyer HU, 1983, Methods of Enzymatic Analysis
  62. 10.1111/j.1742-4658.2005.04610.x · DOI
  63. 10.1016/0014-5793(83)80330-5 · DOI · Paper page
  64. 10.1042/bj2020581 · doi:10.1042/bj2020581
  65. 10.1111/j.1432-1033.1978.tb12042.x · doi:10.1111/j.1432-1033.1978.tb12042.x

Cited by

See all 202

Metadata

Authors
Marín‐Hernández, A., Rodríguez‐Enríquez, S., Vital‐González, P. A., Flores‐Rodríguez, F. L., Macías‐Silva, M., Sosa‐Garrocho, M., & Moreno‐Sánchez, R.
Venue
The FEBS Journal
Publisher
Wiley
Published
2006-04-05
Volume
273
Issue
9
Pages
1975-1988
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W1542830184
Cited by
202
References
2
FWCI
2.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determining and understanding the control of glycolysis in fast‐growth tumor cells: Flux control by an over‐expressed but strongly product‐inhibited hexokinase. https://app.cochat.ai/papers/10.1111/j.1742-4658.2006.05214.x
The paper
Marín‐Hernández, A., Rodríguez‐Enríquez, S., Vital‐González, P. A., Flores‐Rodríguez, F. L., Macías‐Silva, M., Sosa‐Garrocho, M., & Moreno‐Sánchez, R. (2006). Determining and understanding the control of glycolysis in fast‐growth tumor cells: Flux control by an over‐expressed but strongly product‐inhibited hexokinase. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2006.05214.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.